Anti-VEGF medicines
These medicines reduce signalling that causes abnormal blood-vessel growth and leakage. Choice and interval are individual clinical decisions.
Shifa International Hospital, Islamabad
Retinal treatment
Intravitreal injections deliver medicine inside the eye for selected retinal conditions. The diagnosis and OCT response determine the drug and schedule.
Contact the treating eye service immediately for increasing pain, marked redness, worsening vision, pus-like discharge or severe light sensitivity after an injection.
Understanding the concern
Eye injections are commonly used to treat retinal swelling or abnormal blood vessels in conditions such as wet AMD, diabetic macular oedema and retinal vein occlusion. Steroid medicines are used in selected circumstances.
The injection itself is brief, but the treatment pathway includes confirming the diagnosis, cleaning and numbing the eye, monitoring response and recognising the rare symptoms that need urgent review.
What patients notice
These features can overlap with other eye conditions. Examination is needed to establish the cause.
Specialist assessment
The decision is based on the underlying condition and activity seen on examination and imaging, not on blurred vision alone.
OCT measures retinal fluid and structural change and is central to deciding when treatment is active or stable.
The macula, optic nerve, vitreous and peripheral retina are reviewed for disease and other causes of visual change.
Previous response, allergies, infection, surgery and relevant medical conditions are considered before treatment.
Treatment planning
Protocols vary. Many conditions require a series of injections followed by treatment intervals adjusted to disease activity.
These medicines reduce signalling that causes abnormal blood-vessel growth and leakage. Choice and interval are individual clinical decisions.
Steroids may be used in selected retinal swelling or inflammatory conditions and require monitoring for pressure and cataract-related effects.
Some diseases also require laser, systemic risk-factor management or surgery in addition to injections.
Retinal treatment
At a glance
Prof. Amer Awan uses intravitreal therapy for selected cases of AMD, diabetic retinal disease and retinal vascular conditions. The medicine and treatment frequency depend on examination, imaging and response over time.
Questions patients ask
Numbing medicine is used and the procedure is brief. Pressure or momentary discomfort can occur, and antiseptic may cause surface irritation afterward.
The underlying disease can remain active or recur. OCT and vision are monitored so the interval can be adapted to response.
Mild grittiness or a small moving bubble can occur. Increasing pain, marked redness or worsening vision are not routine and need urgent contact with the treating service.
Vision may be blurred from drops or treatment. Ask the clinic in advance and arrange transport when advised.
Continue reading
General information sources: Prof. Amer Awan - current public profile; National Eye Institute - Injections to treat eye conditions.